Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma.
Lauren R SchaffDean CarlowRyan SchofieldVenissala WongchaiJuli MadzsarAllison HydeAnne S ReinerKatherine S PanageasLisa M DeAngelisIngo K MellinghoffMina LobbousLouis Burt NaborsChristian GrommesPublished in: JCO oncology practice (2024)
Outpatient HD-MTX with glucarpidase is safe and well-tolerated and has the potential to alter standard treatment for CNS lymphoma.